The Correlation of Signal to Noise Ratio Value on DPOAE with Malondialdehyde Levels in Rattus Norvegicus Diabetes Model

Document Type : Original


Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.


The aim of this study was to determine the correlation of the signal-to-noise ratio (SNR) value on distortion product otoacoustic emissions (DPOAE) examination with malondialdehyde (MDA) levels in a diabetic rat model.
Materials and Methods:
The subjects of this study were 25 rats. The samples were divided into 5 groups (days of confirmed diabetes): group 1 (control/non-treatment); group 2 (3 days); group 3 (6 days); group 4 (9 days); and group 5 (12 days). Samples that confirmed diabetes were assessed by DPOAE examination and subjected to MDA-level examination. The data were processed using SPSS and considered significant if p <0.05.
The study showed a decrease in SNR values and an increase in MDA levels for the rats, which was confirmed by diabetes. The most significant result was shown by group 5, which compared to the other diabetes groups. A post hoc test showed the significant difference SNR value in each group (p<0.05); except for groups 1 and 2, the MDA levels showed significant differences for all groups. The Pearson correlation test showed a negative correlation between SNR values and MDA levels. A significant correlation between SNR values and MDA levels was found in group 5.
The study showed a correlation of SNR values from DPOAE examination to MDA levels in diabetes rats, indicating that there has been tissue damage (cochlea), which is characterized by a decrease in the SNR value.


Main Subjects

  1. Kim MB, Zhang Y, Chang Y, Ryu S, Choi Y, Kwon MJ, et al. Diabetes mellitus and the incidence of hearing loss: a cohort study. Int J Epidemiol 2017; 46(2): 717-726.
  2. Pieme CA, Tatangmo JA, Simo G, Nya PCB, Moor VJA, Moukette BM, et al. Relationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetes. BMC Research Notes 2017; 10(141):1-2
  3. Tiwari A, Mudhol RS. Prevalence of sensorineural hearing among type-II diabetes mellitus patient attending KLES Dr. Prabhakar Kore Hospital and MRC: A cross sectional study. Indian J. Med. Res 2018; 18(2): 165-169.
  4. Aladag I, Eyibilen A, Guven M, Atis O, Erkokmaz U. Role of oxidative stress in hearing impairment in patients with type two diabetes mellitus. J Laryngol Otol 2009;123(9): 957-953.
  5. Agarwal AC, Pujary K, Ganapathy K, R B, Nayak DR, Hasan F. Pure tone audiometry and otoacoustic emissions for the assessment of hearing loss in diabetic patients. Indian J. Otol 2013; 19(1): 13-17.
  6. Xipeng L, Ruiyu L, Meng L, Yanzhuo Z, Kaosan G, Liping W. Effects of Diabetes on Hearing and Cochlear Structures. J Laryngol Otol 2013; 8(2): 82-87.
  7. Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. Markers of Oxidative Stress during Diabetes Mellitus. J. Biomark 2013; 1-8.
  8. Ighodaro OM, Adeosun AM, Akinloye OA. Alloxan Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants in experimental studies. Medicina 2017;53(6): 365-374.
  9. Rani K, Gavel P, Bharti S. MDA, Oxidative Stress Marker-Role in Diabetic Nephropathy With Special Reference to Type II Diabetes Mellitus Medical Science Keywords. Indian j. Appl. res 2019; 6(5): 128-130.
  10. Vesperini E, Giacobbe D, Passatore M, Vesperini G, Sorgi C, Vespasiani G. Audiological screening in people with diabetes. First results. Audiol Res 2011; 1(1): 25-27.
  11. Paluru R, Indla YR, C R, Santhakumari R. Otoacoustic Emissions Type 2 Diabetes: A Systematic Review. Int. J. Res. Ayurveda Pharm 2016; 250-251.
  12. Felicio JS, Silva LS, Martins Cl, Neto JFA, Lemos MN, Resende FS, et al. Cochlear Dysfunction and Microvascular Complications in Patient with Type 1 Diabetes Mellitus. Diabetol Metab Synd 2018; 10(81): 2-9.
  13. Luka CD, Olatunde A, Tijjani H, Enewe O. Effect of Aqueous Extract of Phaseolus Vulgaris L. (Red Kidney Beans) on Alloxan-Induced Diabetic Wistar Rats. IJSIT 2013; 2(4): 292-301.
  14. Mishra US, Pradhan SR, Palai S. Evaluation of Left Ventricular Function in Type-2 Diabetes Mellitus with Microalbuminuria. Evid. Based Med. Healthc 2020; 7(8): 385-389.
  15. Paksoy M, Ayduran E, Sanh A, Eken M, Aydm S, Oktay AZ. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 2010; 28(2):615-621.
  16. Shakeel M, Hasan AS, Hashmi FS, Ullah H. Assessment of Hearing Loss and Prognosis in Middle Ear Ventilation Disorders Based on Otoacoustic Emissions. J Int Adv Otol 2010; 6(1): 67-7.


  1. Lee KY. Pathopysiology of Age-Related Hearing Loss (Peripheral and Central). Korean J. Audiol 2013; (17):45-49.
  2. Aluwong T, Ayo JO, Kpukle A, Oladipo OO. Amelioration of hyperglicemia, oxidative stress and dyslipidemia in alloxan-induced diabetic Wistar rats treated with prebiotics and vitamin C. MDPI 2016. 8(5): 2-16.
  3. Erkan SO, Tuhanioglu B, Gurgen SG, Ozdas T, Tastekin B, Pelit A, et al. The Effect of Resveratrol on the Histologic Characteristics of the Cochlea in Diabetic Rats. The Triological Society 2018; 129(1): 1-6.
  4. Karabulut H, Karabulut I, Dagli M, Bayazit YA, Bilen S, Aydin Y, et al. Evaluation of outer hair cell and medial olivocochlear efferent system in patients with type II diabetes mellitus. Turk J Med Sci 2014; 44(1): 150-156.
  5. Qujeq D, Aliakbarpour HR, Kalavi K. Relationship between malondialdehyde level and glutathione peroxidase activity in diabetic rats. Clin. Chim. Acta 2004; 340: 79-83.
  6. Gwarzo MY, Ahmadu JH, Ahmad MD, Dikko AU. Serum Glucose and Malondialdehyde Levels in Alloxan Induced Diabetic Rats Supplements with Methanolic Extract of Tacazzea Apiculata. Int J Biomed Sci 2014; 10(4): 236-242.